跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial
Approved
STANDARD
CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial
Interpharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
e1e01f11bd0e15c0
Company
Interpharma Pty Ltd
Type
Standard
Approval Details
Approval Id
e1e01f11bd0e15c0
Product Name
CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial
Artg Id
320982
Artg Name
CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial
Sponsor
Interpharma Pty Ltd
Company Detail Path
/organization/interpharma-pty-ltd
Artg Date
2020-10-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/37c675eb67e30f41f6e9edbb6dc7012b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/007de5a292f667be596a41958dba7d88.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
e1e01f11bd0e15c0
Type
Standard
Back to TGA Approvals